Kalvista Pharmaceuticals, Inc.

Biotechnology • Healthcare • Cambridge, MA, United States • KALV (NGM)

KalVista Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is EKTERLY, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. KalVista Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

857 999 0075 55 Cambridge Parkway, Cambridge, MA 02142, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

How KalVista Pharmaceuticals Inc. (4XC1) stock moves in volatile trading sessions - Price-to-Book Ratio Updates & Buy Sell Timing Alerts - bollywoodhelpline.com

bollywoodhelpline.com • Jan 1

KalVista Pharmaceuticals (NASDAQ:KALV) Trading 5.1% Higher - Should You Buy? - MarketBeat

MarketBeat • Dec 30

Precision Trading with Kalvista Pharmaceuticals Inc. (KALV) Risk Zones - Stock Traders Daily

Stock Traders Daily • Jan 1

Japan approves first pill to treat sudden hereditary angioedema attacks - Stock Titan

Stock Titan • Dec 22

KalVista Pharmaceuticals Stock Sees RS Rating Rise To 82 - Investor's Business Daily

Investor's Business Daily • Aug 27

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has KalVista Pharmaceuticals, Inc. had layoffs?

No layoff events have been recorded for KalVista Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does KalVista Pharmaceuticals, Inc. have?

KalVista Pharmaceuticals, Inc. has approximately 270 employees.

What industry is KalVista Pharmaceuticals, Inc. in?

KalVista Pharmaceuticals, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is KalVista Pharmaceuticals, Inc. a publicly traded company?

Yes, KalVista Pharmaceuticals, Inc. is publicly traded under the ticker symbol KALV on the NGM. The company has a market capitalization of approximately $0.77 billion.

Where is KalVista Pharmaceuticals, Inc. headquartered?

KalVista Pharmaceuticals, Inc. is headquartered in Cambridge, MA, United States at 55 Cambridge Parkway, Cambridge, MA 02142, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.